About the Journal

Acta Medica Indonesiana—The Indonesian Journal of Internal Medicine is an open-access online journal and a comprehensive peer-reviewed medical journal that has been owned and published by the Indonesian Society of Internal Medicine since 1968. Our main mission is to encourage novel and important science in the clinical area of internal medicine.

The journal aims to disseminate high-quality scientific findings to a global audience and promote scientific advancement in medical practice and education.

FOCUS AND SCOPE

We welcome authors for original articles (research), review articles, interesting case reports, special articles, clinical practices, and medical illustrations that focus on the clinical area of internal medicine.

Subjects suitable for publication include, but are not limited to, the following fields:

  • Internal Medicine
  • Allergy and immunology
  • Emergency medicine
  • Cancer and stem cells
  • Cardiovascular
  • Endocrinology and Metabolism
  • Gastroenterology
  • Gerontology
  • Hematology
  • Hepatology
  • Tropical and Infectious Disease
  • Virology
  • Internal medicine
  • Psychosomatic
  • Pulmonology
  • Rheumatology
  • Renal and Hypertension
  • Thyroid

 

EDITORIAL PROCESS

An editor will check the submitted manuscript for its suitability with the Acta Medica Indonesiana focus and scope and major methodological flaws within two weeks. The editor will also check the grammar and ensure that a professional native English proofreader has evaluated the manuscript. Every submitted manuscript that passes this step will then be checked for plagiarism by Turnitin and/ or Viper by scanmyessay. If there is evidence of minor plagiarism, the paper must be revised; if there is evidence of severe plagiarism, it will be rejected.

The next step is a screening process based on the EQUATOR-network guidelines and our journal's author guidelines to assess the manuscript’s eligibility before it proceeds to peer review. Then, the editor-in-charge will be assigned to the manuscript. Subsequently, the manuscript will go through peer-review process. The revisions may be required and will be re-evaluated by the editor-in-charge after the authors provide sufficient responses. The manuscript will be passed to the editor-in-chief for any further revision, and ultimately will undergo an editorial decision.

The accepted manuscript proceeds to the copyediting phase for spelling and grammatical checks, standardization of the journal’s in-house style, table and figure enhancements, and general writing quality enhancements. A pending scheduled publication will result from this stage's unfinished revision. The document will next enter the typesetting stage of production. The author receives a PDF file for approval; no further scientific alterations should be made. Since the editor must approve the revisions, noncompliance will cause the publication to be delayed. Before anything is published, the corresponding author must give their final approval.


PEER-REVIEW PROCESS

Our journal uses the standard reviewing process from OJS to manage the review process. The Standard Review Process has its steps reviewers through the process, ensures a complete review history for each submission, and takes advantage of automatic reminder notifications and standard recommendations for submissions (Accept, Accept with revisions; Submit for review; Submit elsewhere; Decline; See comments).

An editor first reviews the submitted manuscript. It will be evaluated in the office whether it is suitable for our focus and scope or has major methodological flaws. Every submitted manuscript that passes this step will be checked to identify any plagiarism before being reviewed by reviewers. One of the reviewers is appointed from other institutions (national or international). This journal uses double-blind review, The manuscript will be sent to the reviewer anonymously. Reviewers' comments are also sent anonymously to the corresponding author to take the necessary actions and responses. The decision on the revised manuscript will then be evaluated in an editorial board meeting, the final decision of whom are sent to the corresponding author.

Editors will email selected Reviewers the title and abstract of the submission, as well as an invitation to log into the journal website to complete the review. Reviewers enter the journal website to agree to do the review, to download submissions, submit their comments, and select a recommendation.

 

OPEN-ACCESSED POLICY

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

This journal adheres to the DOAJ’s criteria for open-access publications, ensuring that the content is freely accessible to readers and made available under an open-access license, such as Creative Commons.

To support the costs of high-quality publishing—including peer review management and journal production—an Article Processing Charge (APC) is applied upon acceptance of the manuscript.

 

PUBLICATION FREQUENCY

This journal is published quarterly in a year.

 

PUBLICATION ETHICS AND MALPRACTICE STATEMENT

Acta Medica Indonesiana is committed to upholding the highest standards of publication ethics and taking all possible measures against publication malpractice. This statement is based on the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) guidelines.      

Studies on human subjects should have ethical clearance from the Institutional Review Board (IRB), and a copy of the ethical clearance letter should be submitted in the supplementary files.

When reporting/writing experimental results with certain objects (i.e., patients’ names, institution, or others), one should never mention identity or other characteristics that describe that object.

All authors must have significantly contributed to the submitted manuscript. Any conflicts of interest must be disclosed (submit a copy of the signed consent form for authors).

Authors must present original work, free from plagiarism and data fabrication. The Acta Medica Indonesiana strictly prohibits plagiarism, data falsification, duplicate publication, and authorship manipulation. All cases of suspected misconduct will be investigated following COPE guidelines.

Authors or editors may issue corrections when errors are discovered. Retractions will be issued for articles found to violate ethical standards and will be published when necessary.

Authors guarantee that the manuscript must not be under review or published elsewhere.

The journal's publisher ensures that commercial interests do not influence editorial decisions.

Editorial Responsibilities
- Editors evaluate manuscripts for scientific merit without discrimination.
- Editors ensure a fair, unbiased review process and prevent conflicts of interest.
- Editorial decisions are final and based on the manuscript's relevance and quality.

 

DATA SHARING POLICY

Acta Medica Indonesiana encourages authors to share the data and other materials that support the results presented in their manuscripts. Data should be deposited in a suitable public repository, and a link to the dataset should be provided in the manuscript. In cases where data cannot be shared due to ethical, legal, or privacy constraints, authors must clearly state the reasons in the manuscript’s title page or data availability statement.

By promoting data sharing, Acta Medica Indonesiana aims to enhance published research's transparency, reproducibility, and integrity.

 

COPYRIGHT AND LICENSING

Articles published in Acta Medica Indonesiana are licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing for non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

ARCHIVING

To ensure long-term digital preservation, Acta Medica Indonesiana participates in the CLOCKSS (Controlled Lots of Copies Keep Stuff Safe) archival system. Through CLOCKSS, the journal’s content is preserved in a secure and decentralized network of participating libraries, ensuring permanent access even during journal discontinuation.
For more information, visit https://clockss.org.

Clockss


INDEXING AND ABSTRACTING

Our journal has been accredited by SINTA (DIKTI) and indexed by PubMed/ MEDLINE, SCOPUS, EBSCO, DOAJ, Emerging Science Citation Index (ESCI by Web of Science/ Clarivate), Asean Citation Index, WorldCat, and Google Scholar.

 

ADVERTISING POLICY

Acta Medica Indonesiana is committed to maintaining the integrity of our publication and ensuring the quality of the scientific content we provide. In line with this commitment, we do not accept any form of commercial advertising, sponsorship, or promotional content within our journal or on our website.

Our editorial processes and content are independent and free from any external commercial influence. We prioritize the dissemination of high-quality, peer-reviewed medical research and ensure that all published content adheres to ethical standards, without the influence of advertisers or sponsors.

If you have any questions regarding this policy, please feel free to contact us at: admin@actamedindones.org